-
1
-
-
84884953741
-
Novel therapeutic targets in diffuse large B-cell lymphoma
-
Lenz G. Novel therapeutic targets in diffuse large B-cell lymphoma. EJC Suppl. 2013;11:262-263.
-
(2013)
EJC Suppl.
, vol.11
, pp. 262-263
-
-
Lenz, G.1
-
2
-
-
84920944207
-
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma
-
Witkowska M, Smolewski P. Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma. Immunotherapy. 2015;7:37-46.
-
(2015)
Immunotherapy.
, vol.7
, pp. 37-46
-
-
Witkowska, M.1
Smolewski, P.2
-
3
-
-
84949730904
-
Consortium for Improving Survival of Lymphoma. Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B cell lymphoma patients
-
Shin HJ, Yoon DH, Lee HS, Oh SY, Yang DH, Kang HJ, Chong SY, Park Y, Do Y, Lim SN, Jo JC, Lee WS, Chung J. Consortium for Improving Survival of Lymphoma. Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B cell lymphoma patients. Exp Hematol. 2015; doi: 10.1016/j.exphem.2015.08.008.
-
(2015)
Exp Hematol.
-
-
Shin, H.J.1
Yoon, D.H.2
Lee, H.S.3
Oh, S.Y.4
Yang, D.H.5
Kang, H.J.6
Chong, S.Y.7
Park, Y.8
Do, Y.9
Lim, S.N.10
Jo, J.C.11
Lee, W.S.12
Chung, J.13
-
4
-
-
84920059831
-
The emerging roles of microRNAs in cancer metabolism
-
Chan B, Manley J, Lee J, Singh SR. The emerging roles of microRNAs in cancer metabolism. Cancer Lett. 2015;356:301-308.
-
(2015)
Cancer Lett.
, vol.356
, pp. 301-308
-
-
Chan, B.1
Manley, J.2
Lee, J.3
Singh, S.R.4
-
5
-
-
84923063732
-
Regulation of microRNAs by natural agents: new strategies in cancer therapies
-
Phuah NH, Nagoor NH. Regulation of microRNAs by natural agents: new strategies in cancer therapies. Biomed Res Int. 2014;2014:804510.
-
(2014)
Biomed Res Int.
, vol.2014
, pp. 804510
-
-
Phuah, N.H.1
Nagoor, N.H.2
-
6
-
-
18744396337
-
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F,Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524-15529.
-
(2002)
Proc Natl Acad Sci U S A.
, vol.99
, pp. 15524-15529
-
-
Calin, G.A.1
Dumitru, C.D.2
Shimizu, M.3
Bichi, R.4
Zupo, S.5
Noch, E.6
Aldler, H.7
Rattan, S.8
Keating, M.9
Rai, K.10
Rassenti, L.11
Kipps, T.12
Negrini, M.13
Bullrich, F.14
Croce, C.M.15
-
7
-
-
84924962270
-
Dysregulation of microRNA biogenesis and gene silencing in cancer
-
Hata A, Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal. 2015;8:re3.
-
(2015)
Sci Signal.
, vol.8
, pp. re3
-
-
Hata, A.1
Lieberman, J.2
-
8
-
-
84893645257
-
Small molecule with big role: MicroRNAs in cancer metastatic microenvironments
-
Su Y, Li X, Ji W, Sun B, Xu C, Li Z, Qian G, Su C. Small molecule with big role: MicroRNAs in cancer metastatic microenvironments. Cancer Lett. 2014;344:147-156.
-
(2014)
Cancer Lett.
, vol.344
, pp. 147-156
-
-
Su, Y.1
Li, X.2
Ji, W.3
Sun, B.4
Xu, C.5
Li, Z.6
Qian, G.7
Su, C.8
-
9
-
-
84937886780
-
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
-
Lim EL, Trinh DL, Scott DW, Chu A, Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M, Mottok A, Ennishi D, Johnson NA,Steidl C, Connors JM, Morin RD, Gascoyne RD, Marra MA. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol. 2015;16:18.
-
(2015)
Genome Biol.
, vol.16
, pp. 18
-
-
Lim, E.L.1
Trinh, D.L.2
Scott, D.W.3
Chu, A.4
Krzywinski, M.5
Zhao, Y.6
Robertson, A.G.7
Mungall, A.J.8
Schein, J.9
Boyle, M.10
Mottok, A.11
Ennishi, D.12
Johnson, N.A.13
Steidl, C.14
Connors, J.M.15
Morin, R.D.16
Gascoyne, R.D.17
Marra, M.A.18
-
10
-
-
84907154835
-
MicroRNA and gene networks in human diffuse large B-cell lymphoma
-
Wang K, Xu Z, Wang N, Xu T, Zhu M. MicroRNA and gene networks in human diffuse large B-cell lymphoma. Oncol Lett. 2014;8:2225-2232.
-
(2014)
Oncol Lett.
, vol.8
, pp. 2225-2232
-
-
Wang, K.1
Xu, Z.2
Wang, N.3
Xu, T.4
Zhu, M.5
-
11
-
-
84981354921
-
Investigating the expression of oncogenic and tumor suppressive microRNA in DLBCL
-
Handal B, Enlow R, Lara D, Bailey M, Vega F, Hu P, Lennon A. Investigating the expression of oncogenic and tumor suppressive microRNA in DLBCL. J Assoc Genet Technol. 2013;39:14-20.
-
(2013)
J Assoc Genet Technol.
, vol.39
, pp. 14-20
-
-
Handal, B.1
Enlow, R.2
Lara, D.3
Bailey, M.4
Vega, F.5
Hu, P.6
Lennon, A.7
-
12
-
-
84958779478
-
miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development
-
Feb 18
-
Petrovic N. miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development. Mol Diagn Ther. 2016 Feb 18. doi: 10.1007/s40291-016-0186-3.
-
(2016)
Mol Diagn Ther
-
-
Petrovic, N.1
-
13
-
-
70350457646
-
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
-
Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K, Yamashita J, Saitoh H, Kameoka Y, Shimizu N,Ichinohasama R, Sawada K. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood. 2009;114:3265-3275.
-
(2009)
Blood.
, vol.114
, pp. 3265-3275
-
-
Yamanaka, Y.1
Tagawa, H.2
Takahashi, N.3
Watanabe, A.4
Guo, Y.M.5
Iwamoto, K.6
Yamashita, J.7
Saitoh, H.8
Kameoka, Y.9
Shimizu, N.10
Ichinohasama, R.11
Sawada, K.12
-
14
-
-
84875766140
-
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
-
Di Martino MT, Gullà A, Cantafio ME, Lionetti M, Leone E, Amodio N, Guzzi PH, Foresta U, Conforti F, Cannataro M, Neri A,Giordano A, Tagliaferri P, Tassone P. In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma. Oncotarget. 2013;4:242-255. doi: 10.18632/oncotarget.820.
-
(2013)
Oncotarget.
, vol.4
, pp. 242-255
-
-
Di Martino, M.T.1
Gullà, A.2
Cantafio, M.E.3
Lionetti, M.4
Leone, E.5
Amodio, N.6
Guzzi, P.H.7
Foresta, U.8
Conforti, F.9
Cannataro, M.10
Neri, A.11
Giordano, A.12
Tagliaferri, P.13
Tassone, P.14
-
15
-
-
84938063872
-
The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression
-
Battistella M, Romero M, Castro-Vega LJ, Gapihan G, Bouhidel F, Bagot M, Feugeas JP, Janin A. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression. J Invest Dermatol. 2015;135:1659-1667.
-
(2015)
J Invest Dermatol.
, vol.135
, pp. 1659-1667
-
-
Battistella, M.1
Romero, M.2
Castro-Vega, L.J.3
Gapihan, G.4
Bouhidel, F.5
Bagot, M.6
Feugeas, J.P.7
Janin, A.8
-
16
-
-
84875673906
-
Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma
-
Gu L, Song G, Chen L, Nie Z, He B, Pan Y, Xu Y, Li R, Gao T, Cho WC, Wang S. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma. Acta Haematol. 2013;130:87-94.
-
(2013)
Acta Haematol.
, vol.130
, pp. 87-94
-
-
Gu, L.1
Song, G.2
Chen, L.3
Nie, Z.4
He, B.5
Pan, Y.6
Xu, Y.7
Li, R.8
Gao, T.9
Cho, W.C.10
Wang, S.11
-
17
-
-
84947983650
-
Therapeutic use of MicroRNAs in cancer
-
Tessitore A, Cicciarelli G, Mastroiaco V, Del Vecchio F, Capece D, Verzella D, Fischietti M, Vecchiotti D, Zazzeroni F, Alesse E. 2016, Therapeutic use of MicroRNAs in cancer, Anti-Cancer Agents in Medicinal Chemistry, 16(1), 7-19.
-
(2016)
Anti-Cancer Agents in Medicinal Chemistry
, vol.16
, Issue.1
, pp. 7-19
-
-
Tessitore, A.1
Cicciarelli, G.2
Mastroiaco, V.3
Del Vecchio, F.4
Capece, D.5
Verzella, D.6
Fischietti, M.7
Vecchiotti, D.8
Zazzeroni, F.9
Alesse, E.10
-
18
-
-
84938526301
-
Combinatorial Action of MicroRNAs let-7 and miR-34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation
-
Stahlhut C, Slack FJ. Combinatorial Action of MicroRNAs let-7 and miR-34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation. Cell Cycle. 2015;14:2171-2180.
-
(2015)
Cell Cycle.
, vol.14
, pp. 2171-2180
-
-
Stahlhut, C.1
Slack, F.J.2
-
19
-
-
84924424616
-
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
-
Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM, Saltzman WM, Slack FJ. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 2015;518:107-110.
-
(2015)
Nature.
, vol.518
, pp. 107-110
-
-
Cheng, C.J.1
Bahal, R.2
Babar, I.A.3
Pincus, Z.4
Barrera, F.5
Liu, C.6
Svoronos, A.7
Braddock, D.T.8
Glazer, P.M.9
Engelman, D.M.10
Saltzman, W.M.11
Slack, F.J.12
-
20
-
-
84862182826
-
The duality of oncomiR addiction in the maintenance and treatment of cancer
-
Cheng CJ, Slack FJ. The duality of oncomiR addiction in the maintenance and treatment of cancer. Cancer J. 2012;18:232-237.
-
(2012)
Cancer J.
, vol.18
, pp. 232-237
-
-
Cheng, C.J.1
Slack, F.J.2
-
21
-
-
84933514373
-
MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression
-
Maltby S, Plank M, Ptaschinski C, Mattes J, Foster PS. MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression. Methods Mol Biol. 2015;1220:287-304.
-
(2015)
Methods Mol Biol.
, vol.1220
, pp. 287-304
-
-
Maltby, S.1
Plank, M.2
Ptaschinski, C.3
Mattes, J.4
Foster, P.S.5
-
22
-
-
84934278912
-
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma
-
Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. Oncotarget. 2015;6:15035-15049. doi: 10.18632/oncotarget.3729.
-
(2015)
Oncotarget.
, vol.6
, pp. 15035-15049
-
-
Go, H.1
Jang, J.Y.2
Kim, P.J.3
Kim, Y.G.4
Nam, S.J.5
Paik, J.H.6
Kim, T.M.7
Heo, D.S.8
Kim, C.W.9
Jeon, Y.K.10
-
23
-
-
84931573681
-
Physiological roles of miR-155
-
Mashima R. Physiological roles of miR-155. Immunology. 2015;145:323-333.
-
(2015)
Immunology.
, vol.145
, pp. 323-333
-
-
Mashima, R.1
-
24
-
-
77449128568
-
Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas
-
Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M. Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med. 2009;1:288-295.
-
(2009)
EMBO Mol Med.
, vol.1
, pp. 288-295
-
-
Pedersen, I.M.1
Otero, D.2
Kao, E.3
Miletic, A.V.4
Hother, C.5
Ralfkiaer, E.6
Rickert, R.C.7
Gronbaek, K.8
David, M.9
-
25
-
-
84891803020
-
MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module
-
Jiang D, Aguiar RC. MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. Blood. 2014;123:86-93.
-
(2014)
Blood.
, vol.123
, pp. 86-93
-
-
Jiang, D.1
Aguiar, R.C.2
-
26
-
-
84855857756
-
miR-155 regulates HGAL expression and increases lymphoma cell motility
-
Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS. miR-155 regulates HGAL expression and increases lymphoma cell motility. Blood. 2012;119:513-520.
-
(2012)
Blood.
, vol.119
, pp. 513-520
-
-
Dagan, L.N.1
Jiang, X.2
Bhatt, S.3
Cubedo, E.4
Rajewsky, K.5
Lossos, I.S.6
-
27
-
-
77649242925
-
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis
-
Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A. 2010;107:3111-3116.
-
(2010)
Proc Natl Acad Sci U S A.
, vol.107
, pp. 3111-3116
-
-
Rai, D.1
Kim, S.W.2
McKeller, M.R.3
Dahia, P.L.4
Aguiar, R.C.5
-
28
-
-
84861206450
-
MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)
-
Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A. 2012;109:7865-7870.
-
(2012)
Proc Natl Acad Sci U S A.
, vol.109
, pp. 7865-7870
-
-
Kim, S.W.1
Ramasamy, K.2
Bouamar, H.3
Lin, A.P.4
Jiang, D.5
Aguiar, R.C.6
-
29
-
-
84887310173
-
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice
-
Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CM. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice. Proc Natl Acad Sci U S A. 2013;110:18208-18213.
-
(2013)
Proc Natl Acad Sci U S A.
, vol.110
, pp. 18208-18213
-
-
Sandhu, S.K.1
Fassan, M.2
Volinia, S.3
Lovat, F.4
Balatti, V.5
Pekarsky, Y.6
Croce, C.M.7
-
30
-
-
39749143354
-
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters
-
Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA,Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132:875-886.
-
(2008)
Cell.
, vol.132
, pp. 875-886
-
-
Ventura, A.1
Young, A.G.2
Winslow, M.M.3
Lintault, L.4
Meissner, A.5
Erkeland, S.J.6
Newman, J.7
Bronson, R.T.8
Crowley, D.9
Stone, J.R.10
Jaenisch, R.11
Sharp, P.A.12
Jacks, T.13
-
31
-
-
39749163245
-
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
-
Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008;9:405-414.
-
(2008)
Nat Immunol.
, vol.9
, pp. 405-414
-
-
Xiao, C.1
Srinivasan, L.2
Calado, D.P.3
Patterson, H.C.4
Zhang, B.5
Wang, J.6
Henderson, J.M.7
Kutok, J.L.8
Rajewsky, K.9
-
32
-
-
84860755726
-
The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
-
Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, Chan WC, Fu K. The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia. 2012;26:1064-1072.
-
(2012)
Leukemia.
, vol.26
, pp. 1064-1072
-
-
Rao, E.1
Jiang, C.2
Ji, M.3
Huang, X.4
Iqbal, J.5
Lenz, G.6
Wright, G.7
Staudt, L.M.8
Zhao, Y.9
McKeithan, T.W.10
Chan, W.C.11
Fu, K.12
-
33
-
-
84929268267
-
MicroRNAs in B-cell lymphomas: how a complex biology gets more complex
-
Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015;29:1004-1017.
-
(2015)
Leukemia.
, vol.29
, pp. 1004-1017
-
-
Musilova, K.1
Mraz, M.2
-
34
-
-
84897093330
-
MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy
-
Troppan K, Wenzl K, Deutsch A, Ling H, Neumeister P, Pichler M. MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014;34:557-564.
-
(2014)
Anticancer Res.
, vol.34
, pp. 557-564
-
-
Troppan, K.1
Wenzl, K.2
Deutsch, A.3
Ling, H.4
Neumeister, P.5
Pichler, M.6
-
35
-
-
77957361864
-
Targeting microRNAs in cancer: rationale, strategies and challenges
-
Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9:775-789.
-
(2010)
Nat Rev Drug Discov.
, vol.9
, pp. 775-789
-
-
Garzon, R.1
Marcucci, G.2
Croce, C.M.3
-
36
-
-
84862993281
-
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
-
Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A. 2012;109:E1695-1704.
-
(2012)
Proc Natl Acad Sci U S A.
, vol.109
, pp. E1695-1704
-
-
Babar, I.A.1
Cheng, C.J.2
Booth, C.J.3
Liang, X.4
Weidhaas, J.B.5
Saltzman, W.M.6
Slack, F.J.7
-
37
-
-
84869083907
-
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
-
Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Müller A. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia. 2012;26:2421-2424.
-
(2012)
Leukemia.
, vol.26
, pp. 2421-2424
-
-
Craig, V.J.1
Tzankov, A.2
Flori, M.3
Schmid, C.A.4
Bader, A.G.5
Müller, A.6
-
38
-
-
84921811126
-
Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models
-
Hu H, Qiu Y, Guo M, Huang Y, Fang L, Peng Z, Ji W, Xu Y, Shen S, Yan Y, Huang X, Zheng J, Su C. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models. Oncotarget. 2015;6:1079-1089. doi: 10.18632/oncotarget.2835.
-
(2015)
Oncotarget.
, vol.6
, pp. 1079-1089
-
-
Hu, H.1
Qiu, Y.2
Guo, M.3
Huang, Y.4
Fang, L.5
Peng, Z.6
Ji, W.7
Xu, Y.8
Shen, S.9
Yan, Y.10
Huang, X.11
Zheng, J.12
Su, C.13
-
39
-
-
84878111076
-
An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma
-
Zhang Y, Fang L, Zhang Q, Zheng Q, Tong J, Fu X, Jiang X, Su C, Zheng J. An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma. Mol Oncol. 2013;7:346-358.
-
(2013)
Mol Oncol.
, vol.7
, pp. 346-358
-
-
Zhang, Y.1
Fang, L.2
Zhang, Q.3
Zheng, Q.4
Tong, J.5
Fu, X.6
Jiang, X.7
Su, C.8
Zheng, J.9
-
40
-
-
84973408822
-
Progress on the relationship between miR-125 family and tumorigenesis
-
Yin H, Sun Y, Wang X, Park J, Zhang Y, Li M, Yin J, Liu Q, Wei M. Progress on the relationship between miR-125 family and tumorigenesis. Exp Cell Res. 2015;339:252-260.
-
(2015)
Exp Cell Res.
, vol.339
, pp. 252-260
-
-
Yin, H.1
Sun, Y.2
Wang, X.3
Park, J.4
Zhang, Y.5
Li, M.6
Yin, J.7
Liu, Q.8
Wei, M.9
-
41
-
-
84962324205
-
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
-
Slezak-Prochazka I, Kluiver J, de Jong D, Smigielska-Czepiel K, Kortman G, Winkle M, Rutgers B, Koerts J, Visser L, Diepstra A, Kroesen BJ, van den Berg A. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma. Oncotarget. 2016;7:2391-2400. doi: 10.18632/oncotarget.6165.
-
(2016)
Oncotarget.
, vol.7
, pp. 2391-2400
-
-
Slezak-Prochazka, I.1
Kluiver, J.2
de Jong, D.3
Smigielska-Czepiel, K.4
Kortman, G.5
Winkle, M.6
Rutgers, B.7
Koerts, J.8
Visser, L.9
Diepstra, A.10
Kroesen, B.J.11
van den Berg, A.12
-
42
-
-
84904748161
-
Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
-
Gan R, Yang Y, Yang X, Zhao L, Lu J, Meng QH. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. Cancer Gene Ther. 2014;21:290-296.
-
(2014)
Cancer Gene Ther.
, vol.21
, pp. 290-296
-
-
Gan, R.1
Yang, Y.2
Yang, X.3
Zhao, L.4
Lu, J.5
Meng, Q.H.6
-
43
-
-
84939183228
-
Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis
-
Cai Z, Cao R, Zhang K, Xue Y, Zhang C, Zhou Y, Zhou J, Sun H, Fu XD. Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis. J Biol Chem. 2015;290:19967-19975.
-
(2015)
J Biol Chem.
, vol.290
, pp. 19967-19975
-
-
Cai, Z.1
Cao, R.2
Zhang, K.3
Xue, Y.4
Zhang, C.5
Zhou, Y.6
Zhou, J.7
Sun, H.8
Fu, X.D.9
-
44
-
-
84896815728
-
microRNA-17~92 is a powerful cancer driver and a therapeutic target
-
Jin HY, Lai M, Xiao C. microRNA-17~92 is a powerful cancer driver and a therapeutic target. Cell Cycle. 2014;13:495-496.
-
(2014)
Cell Cycle.
, vol.13
, pp. 495-496
-
-
Jin, H.Y.1
Lai, M.2
Xiao, C.3
-
45
-
-
84860755726
-
The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle celllymphoma via PI3K/AKT pathway activation
-
Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, Chan WC, Fu K. The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle celllymphoma via PI3K/AKT pathway activation. Leukemia. 2012;26:1064-1072.
-
(2012)
Leukemia.
, vol.26
, pp. 1064-1072
-
-
Rao, E.1
Jiang, C.2
Ji, M.3
Huang, X.4
Iqbal, J.5
Lenz, G.6
Wright, G.7
Staudt, L.M.8
Zhao, Y.9
McKeithan, T.W.10
Chan, W.C.11
Fu, K.12
-
46
-
-
84890089267
-
Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion
-
Yang X, Du WW, Li H, Liu F, Khorshidi A, Rutnam ZJ, Yang BB. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 2013;41:9688-9704.
-
(2013)
Nucleic Acids Res.
, vol.41
, pp. 9688-9704
-
-
Yang, X.1
Du, W.W.2
Li, H.3
Liu, F.4
Khorshidi, A.5
Rutnam, Z.J.6
Yang, B.B.7
-
47
-
-
84858847737
-
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
-
Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012;5:13.
-
(2012)
J Hematol Oncol.
, vol.5
, pp. 13
-
-
Labbaye, C.1
Testa, U.2
|